EGFR-Driven Behavior and Intrapatient T790M Mutation Heterogeneity of Non-Small-Cell Carcinoma With Squamous Histology

被引：11
|
作者：
Graziano, Paolo [1 ]
de Marinis, Filippo [1 ]
Gori, Bruno [1 ]
Gasbarra, Rita [1 ]
Migliorino, Rita [1 ]
De Santis, Stefano [1 ]
Pelosi, Giuseppe [2 ,3 ]
Leone, Alvaro [1 ]
机构：
[1] San Camillo Forlanini Hosp, Rome, Italy
[2] Fdn Ist Ricovero & Cura Carattere Sci, Ist Tumori, Milan, Italy
[3] Univ Milan, Milan, Italy
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2015年 / 33卷 / 31期
关键词：
LUNG-CANCER; GEFITINIB; ERLOTINIB; PATIENT;
D O I：
10.1200/JCO.2013.49.5697
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：E115 / E118
页数：4
相关论文
共 50 条
  • [21] Mixed Response of Non-Small Cell Lung Cancer Harboring the EGFR T790M Mutation to Osimertinib
    Shinno, Y.
    Goto, Y.
    Sato, J.
    Morita, R.
    Matsumoto, Y.
    Murakami, S.
    Kanda, S.
    Horinouchi, H.
    Fujiwara, Y.
    Yamamoto, N.
    Ohe, Y.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2145 - S2145
  • [22] ROR1 AS A NOVEL THERAPEUTIC TARGET FOR EGFR-MUTANT NON-SMALL-CELL LUNG CANCER (NSCLC) PATIENTS WITH THE EGFR T790M MUTATION
    Karachaliou, Niki
    Drozdowskyj, Ana
    Costa, Carlota
    Angel Molina-Vila, Miguel
    Gimenez-Capitan, Ana
    Vergnenegre, Alain
    Massuti, Bartomeu
    Moran, Teresa
    Majem, Margarita
    Felip, Enriqueta
    Carcereny, Enric
    Garcia-Campelo, Rosario
    Viteri, Santiago
    Heidecke, Cordula
    Estrada-Tejedor, Roger
    Teixido, Jordi
    Bivona, Trever
    Giannikopoulos, Petros
    Ono, Mayumi
    Rosell, Rafael
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S1048 - S1048
  • [23] Inhibition of β-Catenin Enhances the Anticancer Effect of Irreversible EGFR-TKI in EGFR-Mutated Non-small-cell Lung Cancer with a T790M Mutation
    Togashi, Yosuke
    Hayashi, Hidetoshi
    Terashima, Masato
    de Velasco, Marco A.
    Sakai, Kazuko
    Fujita, Yoshihiko
    Tomida, Shuta
    Nakagawa, Kazuhiko
    Nishio, Kazuto
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (01) : 93 - 101
  • [24] Poor Prognosis With Coexistence Of EGFR T790M Mutation And Common EGFR-Activating Mutation In Non- Small Cell Lung Cancer
    Gao, Xuejuan
    Zhao, Yanfeng
    Bao, Yi
    Yin, Wei
    Liu, Liyu
    Liu, Ruchuan
    Yu, Zhengquan
    Zhou, Xiao
    Shuai, Jianwei
    CANCER MANAGEMENT AND RESEARCH, 2019, 11 : 9621 - 9630
  • [25] Osimertinib for patients with EGFR T790M mutation-positive non-small-cell lung cancer who have poor performance status
    Kimura, Madoka
    Nishino, Kazumi
    Imamura, Fumio
    Nakashima, Kazuhisa
    Takahashi, Toshiaki
    Sugimoto, Takeya
    Akamatsu, Hiroaki
    Yamamoto, Nobuyuki
    Daga, Haruko
    Imai, Hisao
    Taira, Tetsuhiko
    Miyashita, Yosuke
    Ko, Ryo
    Hisamatsu, Yasushi
    Murakami, Haruyasu
    ANNALS OF ONCOLOGY, 2018, 29
  • [26] Case report: Neuroendocrine breast carcinoma with a germline EGFR T790M mutation
    Sagan, Olivia A.
    Rothstein, Anna
    Jambunathan, Bhaghyasree
    Hadziahmetovic, Mersiha
    Antoniolli, Anita
    Rashid, M. Hammad
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [27] EGFR T790M Mutation as a Possible Target for Immunotherapy; Identification of HLA-A*0201-Restricted T Cell Epitopes Derived from the EGFR T790M Mutation
    Yamada, Teppei
    Azuma, Koichi
    Muta, Emi
    Kim, Jintaek
    Sugawara, Shunichi
    Zhang, Guang Lan
    Matsueda, Satoko
    Kasama-Kawaguchi, Yuri
    Yamashita, Yuichi
    Yamashita, Takuto
    Nishio, Kazuto
    Itoh, Kyogo
    Hoshino, Tomoaki
    Sasada, Tetsuro
    PLOS ONE, 2013, 8 (11):
  • [28] High ratio of T790M to EGFR activating mutations correlate with the osimertinib response in non-small-cell lung cancer
    Ariyasu, Ryo
    Nishikawa, Shingo
    Uchibori, Ken
    Oh-hara, Tomoko
    Yoshizawa, Takahiro
    Dotsu, Yosuke
    Koyama, Junji
    Saiki, Masafumi
    Sonoda, Tomoaki
    Kitazono, Satoru
    Yanagitani, Noriko
    Horiike, Atsushi
    Inase, Naohiko
    Kasahara, Kazuo
    Nishio, Makoto
    Katayama, Ryohei
    LUNG CANCER, 2018, 117 : 1 - 6
  • [29] Non-invasive urine testing of EGFR activating mutation and T790M resistance mutation in non-small cell lung cancer
    Berz D.
    Raymond V.M.
    Garst J.H.
    Erlander M.G.
    Experimental Hematology & Oncology, 5 (1)
  • [30] Clinical utility of repeated rebiopsy for EGFR T790M mutation detection in non-small cell lung cancer
    Lee, Eun Hye
    Kwak, Se Hyun
    Kim, Kyeong Yeon
    Kim, Chi Young
    Lee, Sang Hoon
    Heo, Seok-Jae
    Chang, Yoon Soo
    Kim, Eun Young
    FRONTIERS IN ONCOLOGY, 2024, 14
12345